SLMCX
Price
$132.73
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
WFSTX
Price
$12.65
Change
-$0.05 (-0.39%)
Updated
Oct 17 closing price
Ad is loading...

SLMCX vs WFSTX

Header iconSLMCX vs WFSTX Comparison
Open Charts SLMCX vs WFSTXBanner chart's image
Columbia Seligman Tech & Info A
Price$132.73
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Allspring Innovation Fund -
Price$12.65
Change-$0.05 (-0.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
SLMCX vs WFSTX Comparison Chart
Loading...
VS
SLMCX vs. WFSTX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLMCX is a Buy and WFSTX is a StrongBuy.

FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 13.6B vs. WFSTX (439M). SLMCX (0.00) and WFSTX (0.00) have matching dividends . SLMCX was incepted earlier than WFSTX: SLMCX (41 years) vs WFSTX (24 years). WFSTX is a more actively managed with annual turnover of: 117.00 vs. SLMCX (13.00). WFSTX has a lower initial minimum investment than SLMCX: WFSTX (1000) vs SLMCX (2000). WFSTX annual gain was more profitable for investors over the last year : 34.25 vs. SLMCX (27.03). SLMCX return over 5 years is better than : 70.82 vs. WFSTX (-1.55).
SLMCXWFSTXSLMCX / WFSTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence41 years24 years-
Gain YTD18.72117.375108%
Front LoadN/AN/A-
Min. Initial Investment20001000200%
Min. Initial Investment IRAN/AN/A-
Net Assets13.6B439M3,098%
Annual Yield % from dividends0.000.00-
Returns for 1 year27.0334.2579%
Returns for 3 years3.97-40.43-10%
Returns for 5 years70.82-1.55-4,568%
Returns for 10 years146.1619.14764%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RUNTX29.410.38
+1.31%
Russell Inv US Small Cap Equity M
SLVIX37.460.31
+0.83%
Columbia Select Large Cap Value Inst2
RRFDX38.520.28
+0.73%
T. Rowe Price Equity Income R
GFVAX16.73N/A
N/A
Goldman Sachs Focused Value A
NALFX69.57N/A
N/A
New Alternatives A